3DICU: Evaluation of Three Dimensional Echocardiography in Critical Care Medicine

Sponsor
University Hospital Inselspital, Berne (Other)
Overall Status
Unknown status
CT.gov ID
NCT03270319
Collaborator
(none)
30
1
25
1.2

Study Details

Study Description

Brief Summary

Comparison of volumetric measurements obtained by three dimensional echocardiography with measurements obtained by thermodilution using a pulmonary artery catheter in the intensive care unit.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Prospective, observational study evaluating three dimensional echocardiography for measuring hemodynamic variables versus the current gold standard (pulmonary artery catheter).

    Critically ill patients with a severly compromised circulation due to a shock state with an advanced hemodynamic monitoring in place and the need for echocardiographic evaluation will be included.

    While performing an echocardiography study stroke volume measurements using the bolus method for thermodilution will concomittantly be measured.

    In case of insufficient image quality we are planning to use SonoVue echo contrast. Once the image quality has improved we will repeat the stroke volume measurements with the bolus thermodilution method while performing the echocardiography.

    The acquired echocardiography loops will then be analysed and measured offline once deferred consent has been obtained. We will then compare the echocardiographic measurements with the measurement obtained by the pulmonary artery catheter (bolus method) - since this is the current reference method.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    30 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Evaluation of Three Dimensional Echocardiography in Critical Care Medicine
    Actual Study Start Date :
    May 1, 2016
    Anticipated Primary Completion Date :
    Dec 1, 2017
    Anticipated Study Completion Date :
    Jun 1, 2018

    Arms and Interventions

    Arm Intervention/Treatment
    ICU patient

    Critically ill patients in our adult intensive care unit with the following characteristics: advanced hemodynamic monitoring in place including pulmonary artery catheter and arterial catheter intubated or tracheostomy in place echocardiography requested by the treating physician intervention of interest: hemodynamic assessment done by echocardiography and thermodilution (pulmonary artery catheter)

    Outcome Measures

    Primary Outcome Measures

    1. Comparison of stroke volume measurement with three dimensional echocardiography to stroke volume measurement by thermodilution [through study completion, an average of 1 year]

      The stroke volume of three to six heart beats will be measured after having performed an echocardiographic study. The stroke volume by thermodilution will be measured during the individual examination.

    Secondary Outcome Measures

    1. Feasibility of right ventricular pressure volume loops [through study completion, an average of 1 year]

      Off-line analysis of pressure time curve for right ventricle using data from pulmonary artery catheter and volume time curve from echocardiographic data. Assessment of feasibility to combine these two curves to a pressure volume loop.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • advanced hemodynamic monitoring with pulmonary artery catheter and arterial catheter in place

    • patient intubated or tracheostomy in place

    • clinical indication for performing an echocardiography

    • ongoing sedation requirement

    Exclusion Criteria:
    • Heart rhythm other than sinus rhythm or paced atrial rhythm

    • Known allergy to sulphur-hexafluoride (SonoVue©)

    • Artificial heart valves in place

    • Any form of mechanical cardiac assist

    • contraindication to performing a transesophageal echocardiography

    • presence of significant cardiac valve regurgitation

    • presence of an intracardiac shunt

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Department for Intensive Care Medicine Bern Switzerland 3010

    Sponsors and Collaborators

    • University Hospital Inselspital, Berne

    Investigators

    • Principal Investigator: Andreas Bloch, MD, department of intensive care medicine, Inselspital, university hospital Berne, university of Berne, Switzerland

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital Inselspital, Berne
    ClinicalTrials.gov Identifier:
    NCT03270319
    Other Study ID Numbers:
    • 16032016
    First Posted:
    Sep 1, 2017
    Last Update Posted:
    Sep 1, 2017
    Last Verified:
    Aug 1, 2017
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University Hospital Inselspital, Berne

    Study Results

    No Results Posted as of Sep 1, 2017